Afinitor 5 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Afinitor 5 mg Tablet contains everolimus, an mTOR inhibitor. Its labelling describes it for the treatment of certain cancers — including breast, kidney, pancreatic, and lung cancer — given alone or with other medicines, and for the prevention of organ rejection in transplant patients by regulating the immune system so it accepts the new organ. It is taken at the same time each day, with or without food as directed.
Product Information
The following description reflects information associated with everolimus and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the prevention of organ rejection in transplant patients, including kidney transplant rejection
- Described for the treatment of breast cancer
- Described for the treatment of kidney, pancreatic, and lung cancer
- Described as regulating the immune system or, in cancer, slowing the growth of cancer cells
Described Dosage & Administration
- Swallowed whole with or without food, at a fixed time each day; tablets should not be crushed, broken, or chewed
- The dose, duration, and whether to take it before or after a meal are set by the doctor
- A double dose or overdose should be avoided
Described Side Effects
Commonly described side effects include:
- Decreased appetite and weight loss
- Raised blood glucose
- Joint pain
- Rash
- Diarrhoea
- Infection
- Breathlessness
- Inflammation of the mouth (stomatitis)
- Tiredness (fatigue)
- Anaemia (low number of red blood cells)
- Change in taste
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- A complete medical history should be shared with the doctor
- The doctor should be told if the patient is pregnant, breastfeeding, or planning a pregnancy in the near future
- Any persistent side effect, such as ongoing fatigue or cough, should be reviewed by a clinician
- The tablet should be taken at the same time each day as directed
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains everolimus, an mTOR inhibitor used for the prevention of organ transplant rejection and for the treatment of certain cancers, including breast, kidney, pancreatic, and lung cancer. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole at a fixed time each day, with or without food as directed, and not crushed, broken, or chewed. A double dose should be avoided.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.